Publications by authors named "P L Berry"
The evolving landscape of live biotherapeutics in the treatment of Clostridioides difficile infection.
Indian J Gastroenterol
January 2025
Clostridioides difficile (C. difficile) infection (CDI) is common after antibiotic exposure and presents significant morbidity, mortality and healthcare costs worldwide. The rising incidence of recurrent CDI, driven by hypervirulent strains, widespread antibiotic use and increased community transmission, has led to an urgent need for novel therapeutic strategies.
View Article and Find Full Text PDFBackground: The Government of India undertook several measures for COVID-19 pandemic, of which school closure was one. This led to sudden shift of teaching methods from classroom-based to online mode. This study aimed to understand the effects of school closure on children during lockdown period.
View Article and Find Full Text PDFDischarging the duty of candor following delayed post-endoscopy cancer diagnosis.
Endosc Int Open
November 2024
Endoscopic examination is not risk free. Not only are there well-known complications associated with the procedure, but malignant and pre-malignant lesions can be missed due to human factors or failures in organizational process. Duty of candor (DoC) is a legal requirement if significant harm occurs in delivery of healthcare.
View Article and Find Full Text PDFArticle Synopsis
- - Lolium multiflorum (Italian ryegrass) is found in Oregon as both a weed and a crop, and herbicide-resistant populations have developed due to chemical management practices.
- - A glyphosate-resistant population identified in Yamhill County shows a nine-fold increase in resistance to glyphosate compared to a susceptible group, with no known amino acid mutations linked to resistance.
- - The resistance is linked to a significant increase (30-fold) in copies of the EPSPS gene, marking the first instance of this type of genetic amplification in glyphosate-resistant L. multiflorum in Oregon.
Article Synopsis
- * Study results show that olaparib effectively targets PARP-1 in glioblastoma cells, leading to reduced cell growth and increased apoptosis, particularly when combined with radiation.
- * Findings indicate that delivering olaparib directly to the tumor area, alongside standard treatments like temozolomide or etoposide, significantly improves long-term survival in glioma models.